Trials / Conditions / Primary Invasive Breast Cancer
Primary Invasive Breast Cancer
4 registered clinical trials studyying Primary Invasive Breast Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | EndoPredict® Extended Endocrine Trial (EXET) NCT04016935 | Myriad Genetic Laboratories, Inc. | — |
| Active Not Recruiting | Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer NCT03503799 | North Eastern German Society of Gynaecological Oncology | — |
| Completed | A Prototype Tri-modal Imaging Device for Breast Cancer NCT02794064 | University Health Network, Toronto | Phase 1 |
| Terminated | Capecitabine in Women With Operable Breast Cancer NCT00148720 | Dana-Farber Cancer Institute | Phase 2 |